THE EFFECTS OF INDUCED SLEEP FRAGMENTATION ON CARDIAC SYMPATHOVAGAL BALANCE by Zeiner, John
THE EFFECTS OF INDUCED SLEEP FRAGMENTATION ON CARDIAC SYMPATHOVAGAL BALANCE  
 
 
 
 
 
 
 
 
 
 
 
by 
 
 
John Richard Zeiner Jr. 
 
 
B.S., University of Pittsburgh, 2003 
 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of  
 
 
Graduate School of Public Health in partial fulfillment 
 
 
of the requirements for the degree of  
 
 
Master of Science 
 
 
 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
 
 
2009
 
 
 UNIVERSITY OF PITTSBURGH 
 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
 
 
 
 
This thesis was presented 
 
by 
 
John Richard Zeiner Jr. 
 
It was defended on 
 
April 16, 2009 
 
and approved by 
 
 
 
 
 
 
 
 
Thesis Advisor:  
Vincent C. Arena, PhD 
Associate Professor 
Department of Biostatistics 
Graduate School of Public Health 
University of Pittsburgh 
 
Committee Member: 
Gary Marsh, PhD  
Professor 
Department of Biostatistics 
Graduate School of Public Health 
University of Pittsburgh 
 
Committee Member: 
Ada Youk, PhD 
Research Assistant Professor  
Department of Biostatistics 
Graduate School of Public Health 
University of Pittsburgh 
 
Committee Member: 
Mark Sanders, MD 
Professor  
Department of Medicine 
School of Medicine 
University of Pittsburgh 
ii 
 Vincent C. Arena, PhD 
 
 
 
 
 
THE EFFECTS OF INDUCED SLEEP FRAGMENTATION ON CARDIAC SYMPATHOVAGAL BALANCE 
  
John Richard Zeiner Jr., MS 
 
 
University of Pittsburgh, 2009 
 
Abstract 
 
Obstructive Sleep Apnea Hypopnea (OSAH) is a prevalent disorder that occurs in about 5% of the middle-
aged adult population.  Comprised of repetitive episodes of complete and/or partial upper airway obstruction during 
sleep, OSAH results in cyclic oxyhemoglobin desaturation-resaturation (e.g. intermittent hypoxia) and arousal from 
sleep (sleep fragmentation).  Consequences of OSAH include increased risk of cardiovascular morbidity and 
mortality and elevated sympathetic activity (SA) during daytime wakefulness as well as sleep. 
This has potential clinical relevance because heightened SA is thought to be one mechanism explaining the 
association between OSAH and cardiovascular disease.  Although OSAH is associated with increased sympathetic 
contribution to cardiac sympatho-vagal balance (SVB), the pathway mediating this effect (intermittent hypoxia, 
sleep fragmentation (SF) or both) is unclear. Because obstructive upper airway events in OSAH patients precipitate 
both physiologic phenomena in a generally concomitant manner, it has been difficult to sort the individual 
contributions of each in clinical populations. 
The aim of this study was to investigate the relationship between SVB and experimentally induced SF 
including examination of the possible interaction with being overweight in a healthy non-OSAH population.   
Twenty-nine subjects entered into a 4 night / 3 day sleep study to evaluate the effect of experimentally 
induced SF.  Subjects provided a spectrum of body mass index (BMI) ranging from normal to overweight.  Subjects 
experienced two nights of undisturbed sleep followed by two nights of fragmented sleep.  Awake SVB reflected by 
heart rate variability was measured during wakefulness before and after a night of undisturbed sleep and a night of 
fragmented sleep.  Sleep duration and architecture were assessed under both sleep conditions.   
SVB was decreased by transient changes from awake to sleep.  SVB was affected by SF on an undisturbed 
night, but not a disturbed night.  BMI had no effect.  The public health significance of this study was that both 
iii 
 OSAH and increased SVB have increased risk of cardiovascular disease; through improved understanding of the 
relationship between particular components of OSAH (SF or oxygenation-reoxygenation cycle) and increased SVB 
could lead to improved treatment of OSAH and the reduction of cardiovascular disease in the  population.   
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1. Introduction 
 
The intermittent complete and partial upper airway obstructions (apnea and hypopnea, 
respectively) during sleep that characterize obstructive sleep apnea hypopnea (OSAH) brings 
about two fundamental physiologic consequences: episodic, intermittent hypoxia reflecting the 
oxyhemoglobin desaturation during the apneas / hypopneas with subsequent resaturation when 
the airway reopens  on termination of the event; as well as arousal from sleep which is usually 
temporally linked to termination of the events.  The specific contribution of each of these 
consequences to abnormal cardiac sympathovagal balance (SVB) and adverse clinical outcome is 
uncertain.  This study is relevant since previous research has shown that OSAH patients have 
increased sympathetic activation during wakefulness and sleep and that this is independent of 
obesity which is a prevalent condition in this patient population. 
Due to the physiologic and temporal linkage within apnea and hypopnea events, it is 
difficult to separately assess the effects of intermittent hypoxia and sleep fragmentation (arousal) 
on SVB in OSAH patients.  Because OSAH therapy simultaneously alleviates intermittent 
hypoxemia and sleep fragmentation, it is not useful in determining the independent physiological 
impact of each phenomenon.  OSAH patients tend to have various other co-morbidities that 
could affect SVB.  Consequently a model of sleep fragmentation was used in otherwise normal 
human subjects (non-OSAH) to assess the specific impact of sleep disruption on SVB.   
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 It was hypothesized that overnight sleep fragmentation would alter SVB as reflected by 
spectral analysis of heart rate variability (HRV) during wakefulness in the next morning such 
that: 1) Sympathetic activity, measured by HRV shortly after awakening in the morning, would 
increase with experimentally induced fragmented sleep compared to undisturbed sleep over the 
preceding night and, 2) the increase would be exaggerated by obesity after controlling for other 
covariates known to affect HRV and OSAH. 
Specifically, this thesis evaluates the effect of sleep on HRV.  First the effect of transient 
sleep intervals on HRV recorded during periods of behaviorally assessed wakefulness (“awake” 
HRV recordings) will be assessed and the outcome of this assessment will be the measure used 
in subsequent analyses.  Univariate statistical comparisons will be made comparing the HRV 
measured at different time points.  Statistically significant comparisons will be further evaluated 
through assessment of multivariate regression models, specifically looking for the effect of sleep 
fragmentation and for the effect of being overweight on HRV.   
The second aspect of this thesis is the design, implementation and maintenance of a data 
management system for the Obstructive Sleep Apnea and Metabolic Syndrome: Role of 
Oxidative Stress (OSAMSOS) project. The OSAMSOS project is the parent study from which 
the data for these analyses are derived. The management system was designed around a user 
friendly point and click interface that was specifically developed to address the specific needs of 
the project. The database holds all of the study data and integrates information from the patient 
surveys, sleep studies, laboratory assays, and heart rate information. The system was developed 
using MS Access. 
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2. Background 
 
2.1 Obstructive Sleep Apnea Hypopnea 
 
Over the last three decades, the association between severe OSAH and cardiovascular 
morbidity and mortality has been increasingly recognized.  Several large community studies 
have examined the prevalence of OSAH; Sleep Heart Health Study [1], Wisconsin Sleep Cohort 
[2], and Penn State cohort [3]. As such, OSAH is believed to be common in the community 
(Table 1) and largely under-diagnosed.  Summarizing the data from 7 studies (5 international), 
Punjabi estimated prevalence of OSAH at 3 - 7 % of adult males and 2 – 5% of adult females are 
affected [4].  Young et. al. estimated that mild or asymptomatic OSAH occurs in 20% of the 
adult population (30 to 60 years of age) and that symptomatic OSAH (Table 2) occurs in 5% of 
adult population.[5]  Moreover, because the prevalence of OSAH increases with age until the 7th 
decade, this disorder will be increasingly prevalent as the population ages.  There is some 
evidence suggesting that OSAH prevalence changes at age 65 and the characteristics of those 
with OSAH may be different.[5]  The plateau in prevalence may be due to a survivor bias (that 
is, people with the more severe OSAH have not survived to the 7th decade leaving those who are 
more resistant to the effects and/or those with less severe disorder). 
Untreated severe OSAH is associated with an approximate three to five fold increase in 
cardiovascular mortality[6, 7].  There also appears to be a dose response between increasing 
severity of OSAH and increased incidence of hypertension.[8]  Patients also have increased risk 
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 of cardiovascular morbidity [6, 9] including congestive heart failure and acute coronary 
syndrome [10].  One possible mechanism for the adverse cardiovascular outcomes could be from 
elevated sympathetic nervous activity that is sustained into wakefulness after the overnight sleep 
period in these patients.[11]  Increased cardiac SA independant of OSAH is associated with 
increased mortality in patients with cardiovascular disease (CVD) and [12, 13] increase risk of 
myocardial ischemia and cardiovascular death[14]. 
In patients with OSAH, the upper airway becomes completely occluded or partially 
obstructed during sleep which results in complete cessation (obstructive apnea) or reduced 
airflow (obstructive hypopnea), respectively.  Other apnea patterns include central apneas or 
mixed apneas.  Obstructive apneas and hypopneas are identified when airflow ceases or is 
markedly reduced despite the patient’s persistent respiratory efforts.  Central apneas are 
identified when airflow is absent because the patient has not made respiratory efforts. Whereas 
central apneas often considered a consequence of cardiovascular or cerebrovascular disease [15], 
at least severe OSAH is believed likely to contribute to risk for cardiac and cerebrovascular 
disease.  Mixed apneas reflect an event in which initially there is absent airflow due to absent 
respiratory effort but airflow remains absent when efforts resume. Mixed Apneas are usually 
grouped with obstructive apneas when analyzing breathing during sleep. 
Inspiratory efforts against an occluded or partially obstructed upper airway may result in 
large intra-thoracic pressure swings characterized by generation of abnormal degrees of negative 
intrathoracic pressure. The excessively negative intra-thoracic pressure may influence the 
physiology and function of both the right and left ventricles. While increasing venous return to 
the right ventricle, the negative intra-thoracic pressure impairs left ventricular function by 
increasing after-load.[16]  During the initial portion of the obstructive apnea or hypopnea there 
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 is a reduction in cardiac output and blood pressure. These events also result in reduction in blood 
oxygen level (oxyhemoglobin desaturation or hypoxemia) as shown in Figure 1. With 
progression of the event, the reduced cardiac output, blood pressure and hypoxemia elicits 
compensatory augmentation of sympathetic nervous system activity to maintain homeostatic 
conditions [17].  Termination of apneas and hypopneas are associated with arousal from sleep 
which results in activation of the upper airway dilator muscles, restoration of airway patency and 
ability to generate airflow with inspiratory effort. Arousal is also associated with a transient 
surge in SA [18] which results in further increase in peripheral vascular resistance, an overshoot 
of systemic blood pressure and reduction in cardiac output for a brief interval following 
termination of an obstructive apnea event. 
 
2.2 Obstructive Sleep Apnea Hypopnea and Sympathetic Activity 
 
OSAH patients have increased sympathetic nervous system activation during both 
daytime wakefulness and overnight sleep as reflected by muscle sympathetic nerve activity 
(MSNA) (assessed by microneurography), catecholamine levels (circulating in blood or excreted 
through the urine), and HRV. 
Microneurography is a method that records and permits quantification of efferent nerve 
traffic MSNA.  Assessment of MSNA to gain insight regarding cardiac sympathetic nerve 
activity has typically involved insertion of a microprobe into the peroneal nerve posterior to the 
fibular head.  These studies have demonstrated increased sympathetic nervous traffic during 
daytime wakefulness that appears to be correlated with the severity of OSAH.  [19-21]   
5 
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Circulating and urinary catecholamines have also been employed as a measure of 
systemic sympathetic activity.  Catecholamines (epinephrine and norepinephrine) are elevated in 
normotensive OSAH patients.[21, 22]  While potentially informative, by its nature, 
determinations from urine collections provide samples may be influenced by all conditions 
experienced over a relatively protracted time interval (e.g. collection during wakefulness to 
assess the effect of events during the previous sleep period is likely to be influenced by 
extraneous factors such as exertion and changing posture) and blood sampling is invasive and 
inherently stressful.  On the other hand, assessment of HRV requires a brief period data 
collection from an electrocardiogram thereby providing a non-invasive, non-stressful snapshot of 
cardiac sympathovagal activity.  
HRV is a measure of the temporal variability between heart beats (ventricular 
contractions) reflected on an electrocardiogram (EKG) signal as the “R” wave of the “QRS” 
complex (Figure 2). The power spectrum of the inter-beat variability may be used as an indirect 
measure of cardiac autonomic regulation. [23]   
While observational studies have demonstrated the association between OSAH and 
heightened cardiac sympathetic activity during wakefulness and sleep, therapeutic interventional 
studies have provided compelling evidence of causality.  After 6-12 months of continuous 
positive airway pressure (CPAP) therapy SA can be returned to levels that are comparable to 
those recorded in non-OSAH individuals [22, 24].  CPAP therapy introduces air under relatively 
low levels of pressure into the upper airway and acts as splint to support upper airway patency, 
prevent oxyhemoglobin desaturation and normalize sleep continuity.  Short-term CPAP tends to 
decrease epinephrine levels, suggesting a decrease in SA as suggested by urine catecholamine 
change from day to night.[22]  Six months or more of CPAP therapy has been shown to 
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normalize sympathetic activity during wakefulness as reflected by MSNA.[24-26]  HRV analysis 
has suggested that long term CPAP use is associated with decreased cardiac SA.[27]   
 
 
Table 1: Prevalence of Obstructive Sleep Apnea Hypopnea 
              Prevalence 
First Author (Reference)   N  Diagnostic method Male Female 
           Young [2]   602 Polysomnography 4.0% 2.0% 
           Bixler [3] 1741 Polysomnography 3.9% 1.2% 
           Punjabi [4]  Summary of 7 studies 3 - 7% 2 - 5% 
 
 
 
Table 2: Symptoms of Obstructive Sleep Apnea / Hypopnea 
• Excessive Daytime Sleepiness 
• Habitual Loud Snoring 
• Nocturnal Breathing Pauses, Choking, and Gasping 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 1: Polysomnography demonstrating an Obstructive Apnea Event with associtated 
desatureation / resaturation 
20 second PSG epoch showing an obstructive apnea event (in pink) with associated 
oxyhemoglobin desaturation (in yellow).  C4-A1A2: electroencephalogram (central lead EEG); 
EOG1-A1A2 and EOG2-A1A2: bilateral electrooculograms; EMG1: submental 
electromyogram; C3-A1A2 (electroencephalogram (central lead EEG); EKG2: 
electrocardiogram; TIBS: anterior tibialis (limb) electromyogram; RESP: oral airflow; RESPRS: 
nasal airflow; THORACIC: chest wall movement indicating breathing effort; ABDO: abdominal 
wall movement indicating breathing effort; OXIM: oximetry 
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R to R Interval 
R Wave
P Wave T Wave 
 
 
Figure 2: Electrocardiogram 
 
 
S Wave Q Wave
QRS Complex 
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3. Methodology 
 
3.1 Study Design  
 
A parallel study was designed to assess the effect of moderate overnight sleep 
fragmentation on SVB and a secondary analysis to assess the modifying effect of 
overweight/obesity (see Figure 3 for a summary of the study design).  This analysis was a sub-
study of a larger project to distinguish the effect of sleep fragmentation on various biomarkers 
and metabolic parameters. The current report focuses on the effect of sleep fragmentation on 
SVB.  The 3-day/4night protocol design consisted of observing sleep over a four consecutive 24 
nights.   
On Night 1 subjects had a screening/acclimatization sleep study (polysomnogram, PSG).  
Night 1 screened the subjects for undiagnosed sleep disorders.  This night served a dual purpose 
of acclimatization to the study environment (first night effect) [28], and screening for 
exclusionary OSAH.  First night effect means that unfamiliarity with the environment may 
influence sleep quantity architecture.  Without evidence of exclusionary degrees of OSAH or 
evidence or other abnormal sleep patterns during the acclimation night, the subject continued in 
the protocol. Subjects arrived at the Neuroscience Clinical and Translational Research Center 
(N-CTRC) in Western Psychiatric Institute and Clinic around 7:30pm.  PSG monitoring sensors 
(see section 3.3 Polysomnography below for more details) were placed by trained technicians at 
approximately 8:30pm. For every night of the protocol, the aim of the sleep technicians was to 
10 
 have the subjects start their sleep period by 11 pm.  The morning after night 1 and night 3, at 
7:00 am if not already awake, the subject was awakened by the sleep technician.  PSG sensors 
were removed from the subject and permitted to shower prior to breakfast.  During the day, 
subjects were visually monitored by a member of the research team to ensure maintenance of 
wakefulness.  Subjects were permitted to watch television, access the internet, and have visitors.  
Subjects were on a weight maintaining, low anti-oxidant diet provided by the N-CTRC dietician.  
The diet did not permit caffeine.  Subjects were also asked to refrain from caffeine for at least 24 
hours prior to starting the study protocol.  The screening/acclimatization night PSG (Night 1) and 
baseline data-collection PSG (Night 2) were recorded during undisturbed sleep (no 
experimentally induced sleep fragmentation).  Night 3 and Night 4 reflected nights during which 
there was experimentally-induced sleep fragmentation. 
Ten minute recordings of a single-channel awake EKG signal were made at four different 
time points: evening before night 2 (EBN-2); morning-after-night 2 (MAN-2); evening-before-
night 4 (EBN-4); and, morning-after-night 4 (MAN-4).  The evening EKG recordings were done 
after the monitoring sensors were applied and the subject had rested in bed undisturbed for as 
long as the N-CTRC protocol/orders said (10 minutes).  Ten minute EKG recordings were 
obtained while the subjects were lying quietly in the supine posture and assessed to be 
behaviorally awake (by a N-CTRC technician) along with sleep staging based on PSG.  If there 
was a need, subjects were given the opportunity to void prior to EKG data collections for HRV 
analysis.  The morning EKG recordings were performed after being awakened by a sleep 
technician at 7:00 am.  Subjects were then asked to lay quietly supine, but awake for 10 minutes.  
During the EKG recording, sleep technicians monitored the PSG in real time.  If the technician 
11 
 thought the subject was beginning to doze, they would verbally encourage the subject to remain 
awake. 
After lunch on the day following the baseline data-collection PSG (Night 2), subjects 
were allowed to leave the study area.  Prior to the subject leaving, the study coordinator provided 
reminders of what they should not do [including but not limited to napping, refraining from 
caffeine, snacking.].  Subjects were counseled to return to the N-CTRC by 5 pm, prior to dinner.  
The study coordinator inquired about study violations.  If no violation, then the subjects were 
allowed to continue with the study. 
During nights 3 and 4 sleep fragmentation (arousals) was experimentally induced by the 
technicians attending the PSG. Efforts to induce arousal began after the subject had experienced 
2 minutes of Stage 2 sleep or a deeper sleep stage as determined by real-time visual monitoring 
of the PSG recording by a trained sleep technician. To induce experimental sleep fragmentation 
the sequence of arousal methods were: 
 
1. Tones were sounded through a speaker near the subject’s head utilizing an 
increasing tone (in 10 decibel increments) in until an arousal was recorded or 105 
decibels were reached. If initially unsuccessful in eliciting arousal, a given tone 
intensity was applied once again prior to increasing the decibels.  
2. Clicking sounds were generated through the speaker by turning the microphone 
on and off. 
3. Technician knocked on the door 
4. Technician lightly touched the subject on the leg or shoulder.   
 
12 
 Subsequent arousal attempts were initiated at the last successful tone intensity level, or 105 
decibels whichever was lower. 
 
 
3.2 Study Population 
 
Adult subjects (≥ 18 but < 65 years old) were recruited from the greater Pittsburgh, 
Pennsylvania community area via advertisements: flyers, local newspaper, campus newspaper, 
brochures, direct mailings, and word of mouth.  The population selected for this paper was a 
subset of the larger parent study.  Respondents were pre-screened for major exclusionary features 
during a telephone interview during which time an outline of the study and requirements for 
participation were also explained.  Inclusion criteria are listed in Table 3. The study was 
approved by the Institutional Review Board (IRB) of the University of Pittsburgh.   
Subjects who passed the telephone screening and who were willing to continue with the 
screening process met with a study investigator for a screening medical interview and physical 
examination.  Height and weight were obtained to calculate Body Mass Index (BMI = kilograms 
/ meters2).  Study groups were determined based on BMI: Group 1’s BMI was < 25 and Group 
2’s includes those individuals who are overweight (BMI between 25 and 30) and obese (BMI 
>30).  Age was calculated in years based on date of the in person screening.   
13 
  
 
3.3 Polysomnography 
 
The gold-standard test for assessing sleep and breathing is polysomnography (PSG), 
which represents simultaneous recording of multiple variables reflecting sleep duration, 
architecture (e.g. sleep stages) and continuity (e.g. arousal frequency) as well as parameters of 
breathing and oxygenation. PSG was recorded during sleep, and during the awake EKG on EBN-
2, MAN-2, EBN-4, and MAN-4.  The PSG montage include simultaneous recording of bilateral 
central and occipital - electroencephalogram (EEG), electrooculogram (EOG), submentalis 
electromyogram (EMG), lead V2 electrocardiogram (EKG) lead, nasal air flow was recorded 
using a nasal pressure sensor, and arterial oxyhemoglobin saturation was recorded by finger 
pulse oximetry (SpO2).  PSG signals were digitally recorded and stored as well as displayed on a 
video monitor in real-time. 
Standard PSG was scored according to the criteria described by Rechtschaffen and Kales 
[29].  Sleep was scored in 20 second epochs.  Apneas were defined as complete cessation of 
airflow lasting >10 seconds and hypopneas were defined by  >30% reduction in airflow from 
baseline that lasted >10 seconds and associated with >4% oxyhemoglobin desaturation.[30]  The 
Apnea-Hypopnea index (AHI) was calculated by dividing the sum of the total number of apneas 
and hypopneas by the number of hours slept.  Arousals were identified by criteria of the 
American Sleep Disorders Association (now the American Academy of Sleep Medicine) [31, 32]   
The Sleep Fragmentation Index (SFI) was calculated by dividing the sum of the total number of 
arousals (which would include spontaneous arousals, respiratory arousals, and experimentally 
14 
 induced arousals) and awakenings divided by total hours of sleep.  Average SpO2 during 
overnight sleep readings was measured during sleep.  The percentage of total sleep time (TST in 
minutes) spent with SpO2 <90% (%TST with SpO2 < 90%) was also calculated.  Overnight 
duration of SWS was calculated by the time spent in minutes in Stages 3 and 4 sleep.   
 
 
3.4 Heart Rate Variability Analysis 
 
SVB was estimated by examining the autoregressive spectra of the inter-beat-interval 
(IBI) of the EKG, obtained from a modified chest lead using standard surface electrodes [33]. 
Interest was focused on the high frequency (HF) band (0.15-0.4 Hertz, Hz) and the low 
frequency (LF) band (0.04-0.15 Hz) [34]. The high frequency band is reported to reflect 
parasympathetic activity; the low frequency band reflected sympathetic and parasympathetic 
activity.[33, 35]  The ratio of low to high frequency bands (LHR = LF / HF) is an index of 
sympathovagal balance.  An increase in LHR is thought to be associated with an increase in 
sympathetic activity.  During the four time periods (EBN-2, MAN-2, EBN-4, and MAN-4), 
simultaneous recording of EKG and standard PSG occurred. 
The EKG, was sampled at 1024 Hz and an automated, commercially available algorithm 
extracted the IBI sequence from the EKG signal (Mindware Heart Rate Variability Scoring 
Module, version 2.16; Mindware Technologies Ltd., Columbus, OH).  The EKG signal was 
evaluated by a trained technician for artifacts and edited for arrhythmias and ectopic beats. 
Corrections were made by interpolating preceding/successive beats [36]. Two-minute IBI epochs 
were evaluated and the autoregressive (AR) spectrum for each epoch was estimated using the 
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 Burg algorithm. The order of each AR model in the range of 12 < P < 20 were selected using 
Akaike’s final prediction error [37]. The spectrum was decomposed utilizing the residuals 
theorem. [38] This allows for heart rate variability to be accumulated in two bands (0.04-0.15 Hz 
Eq and 0.15-0.4 Hz Eq.).  Commercially available software was utilized for an automated IBI 
extraction algorithm. 
 
 
 Undisturbed Sleep 
 
Fragmented Sleep 
 
Night 1  Night 2  Night 3  Night 4  
        
Acclimate 
Night 
 Baseline 
Night 
 Experimental 
Night 1 
 Experimental 
Night 2 
 
PSG  PSG  PSG  PSG  
 Evening 
Before 
Night 2 
 Morning 
After 
Night 2 
 Evening 
Before 
Night 4 
 Morning 
After 
Night 4 
 10 
minute 
awake 
EKG with 
PSG 
 10 
minute 
awake 
EKG with 
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 10 
minute 
awake 
EKG with 
PSG 
 10 
minute 
awake 
EKG with 
PSG 
PSG = Polysomnography; EKG = Electrocardiogram 
Figure 3: Study Design Paradigm 
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Table 3: Inclusion Criterion 
• Adults ≥ 18 and < 65 years of age 
• Non-smoker for at least 6 months 
• No historical or physical examination evidence of active cardiopulmonary, neurologic, 
renal, hepatic or thyroid disease (individuals on a stable thyroid replacement were 
included) 
• No history of movement disorder during sleep, or circadian rhythm disorders 
• No excessive daytime sleepiness, Epworth Sleepiness Scale Score < 9 [39, 40] 
• No history of chronic insomnia, mood or affective disorders or other psychiatric disorders 
as assessed by the Patient Health Questionnaire, and Pittsburgh Sleep Quality Index [41] 
• Subjects with a history of Depression who report having no hospitalizations for 
Depression within the previous 3 years and was on a stable regimen of anti-depressants 
for 3 months  
• Subjects must report a regular sleep-wake pattern with an estimated sleep time between 
6.5 and 10.0 hours per night  
• Not taking medications known to affect heme metabolism  
• Ability and willingess to undergo a weight maintaining low antioxidant diet provided by 
study dietician 
• Willingness to avoid cafeinnated beverages and food starting day prior to the start of the 
study periord and during the study period 
• Subjects report consumption of an average of < 1 alcoholic beverage / day 
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Table 3: Inclusion Criterion, continued 
• Ability to understand the study and sign informed consent 
• Women with child-bearing potential must test negative via commercially available urine 
pregnancy test 
• Lived within the greater Pittsburgh, Pennsylvannia area  
• No uncontrolled hypertension (blood pressure: systolic  >150/ diastolic >100) 
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4. Data Management  
 
For the parent study a Microsoft Access database was created with the intention to track, 
enter, and store information about each subject and their test results.  Information about each 
subject would arrive at various times depending on when sample analyses took place (e.g. for 
some analyses samples had to be batched).  To facilitate data management a point and click 
interface was created (Figure 4).   
Data arrived from the labs in either an electronic format or a hardcopy format.  When 
appropriate, the electronic information was copied and pasted directly into the appropriate table.  
Most of the information received from the various labs was in a hardcopy format.  Being that 
data entry was highly susceptible to keystroke errors, electronic forms were created.  The forms 
were setup to mimic the paper version.  In addition, the form also had a double entry feature built 
in to help minimize the possibility of keystroke errors.  Double entry is a method setup to 
compare one entry to another entry made a later time.  If both entries were the same, then the 
original entry was considered valid.  If entries were discrepant then the reason for the difference 
can be checked and the correct value entered. Besides the double entry, validation rules were 
created inside each form to aid in ensuring the entered value was appropriate, for example: TST 
had to be less than the total recording time; AHI value could not be negative; and, total hypopnea 
had to equal the sum of obstructive, central and mixed hypopneas, etc.  Figure 5 shows part of 
the form that was designed for entering sleep reports from the N-CTRC which includes a double 
entry feature.   
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 Not all subjects had complete ascertainment, for example: some subjects’ blood samples 
could not be obtained due to that poor venous access; or, subjects did not complete all four nights 
in the study for some reason.  A study completion form was created to track the amount of 
information collected on each subject.  This allowed the study coordinator to track what 
information / samples were obtained about the subject.  The database was able to generate 
reports regarding samples.  Reports included information such as what samples were available 
from which subject that still needed to be delivered to the lab(s) and what sample is awaiting 
results from the lab.   
The Access database for the parent study provided the information for this thesis.  The 
information stored in the database tables were directly imported into analytical statistical 
packages.  SAS programs were written to directly retrieve information from the database. 
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Figure 4: Example of clickable interface flow in study database 
Example of clickable interface leading to the Demographic Information data entry form.  Black 
arrows point to where the user would click to get to the Demographic Information Form. 
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Figure 5: Form for entering sleep information 
Sleep report data entry form which also includes the setup for double entry. 
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5. Statistical Considerations 
 
5.1 Variable Creation and Consolidation 
 
The awake EKG was recorded for 10 minutes and from this five 2-minute LHR epochs 
were derived. These epochs were combined by averaging so that each person had one averaged 
reading for each time point.  It was noted that there were some subjects that had transient 
changes between sleep / awake state during the “awake” EKG recording.  The variation in sleep / 
awake could affect the HRV recording, and the impact of this was unknown.  For each of the 
four time periods, LHR was calculated three different ways: based on all epochs (LHRALL), 
based on non-sleep epochs (LHRAWAKE), and based on sleep epochs (LHRSLEEP).  Thus, each 2-
minute LHR epoch had six 20-second epochs of sleep staging evaluated.  If any of the epochs of 
sleep staging were scored as any stage of sleep, then the entire 2-minute LHR epoch was 
removed prior to generating the averaged LHRAWAKE.  LHR was also generated by averaging 
values from epochs scored only as a stage of sleep (LHRSLEEP).  Overnight change in LHR was 
calculated as averaged LHR morning minus averaged LHR night as assessed at night 2 
(undisturbed sleep) and night 4 (fragmented sleep). 
SFI, AHI, average SpO2 during sleep, percent TST with SpO2 < 90%, SWS, and TST 
information were all collected from the overnight PSG assessed on undisturbed and fragmented 
sleep and treated as continuous variables. Age was also treated in a continuous fashion.  BMI 
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 was treated as a categorical variable as defined by BMI < 25 kg / m2 as the baseline.  Gender was 
defined as 1 for females and 0 for males (baseline).  Fragmented sleep, treated as a categorical 
variable, was defined as 1 and undisturbed seep was defined as 0 (baseline). 
 
 
5.2 Statistical Methods 
 
The data was analyzed using Statistical Analysis System (SAS) software version 9.2.  
Continuous data were summarized using basic descriptive statistics (mean, standard deviation, 
minimum, and maximum).  PROC UNIVARIATE procedures were used to generate descriptive 
statistics for the continuous variables; Kolmogorov-Smirnov test (K/S) and quantile-quantile 
(QQPLOT) plot of the residuals where used to assess the normality of variables.  When 
appropriate, log transformations were performed and normality reassessed.  LHR in the power 
domain is usually skewed and log transformation of LHR is generally done in the literature for 
parametric analyses.[42]  Values are reported as mean (standard deviation) (minimum: 
maximum). Categorical data was assessed using frequency counts and percentages using a 
PROC FREQ procedure.   
When appropriate a generalized linear model using PROC GLM clustering on the subject 
level was used for comparisons with attention directed towards repeated measures ANOVA.   
Repeated measures multiple linear regression using the PROC MIXED procedure was 
used to analyze the relationship between outcome and predictor variables.  PROC MIXED 
options used were: Method was maximum likelihood estimation (METHOD = ml); subject 
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 option was selected as the study identification variable called id (SUBJECT = id); covariance 
structure was unstructured (TYPE = un).   Significance was selected with an alpha < 0.05. 
Model building was then done by a stepwise selection process.  Variables entered with a 
p < 0.2 and then were removed if p > 0.1.  Regardless of their significance, grouped BMI and 
Sleep Fragmentation indicator variables would remain in the model.  Model comparisons were 
made via -2 log likelihood comparisons utilizing a χ2 distribution.  Residual and fit diagnostics 
were then evaluated and addressed.  Statistical significance of covariates was considered at an 
alpha < 0.05. 
 
 
5.2.1 Statistical Comparisons 
 
To select the appropriate outcome variable (LHRALL, or LHRAWAKE) those individuals that 
had evidence of sleep during the recording of their LHR were assessed.  This was only done for 
participants who had both evidence of sleep and evidence of awake during the same time point.  
A generalized linear model clustering on the subject level was used to assess if there is a 
significant difference between LHRSLEEP compared to LHRAWAKE. A repeated measures ANOVA 
using the PROC GLM procedure was used for the analysis.  If there was no significant difference 
between the awake and sleep recorded LHR epochs then the preference would be to select the 
LHRALL as the outcome variable otherwise the LHRAWAKE would be used. 
The effect of sleep fragmentation on the individual sleep variables (AHI, SWS, SFI,  
average SPO2, % TST with SPO2 < 90%, and TST) was assessed via a paired t-test.  Those 
significant sleep variables were further evaluated in model building as covariates.   
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 Outcome variables comparisons were made of the LHR using a paired t-test (PROC 
TTEST) between the time points to determine if there were differences between time points: 
EBN-2 vs. EBN-4; EBN-2 vs. MAN-2; EBN-4 vs. MAN-4; EBN-2 vs. MAN-4; and, overnight 
change on undisturbed night vs. overnight change on fragmented night.  Those with significant 
differences were further evaluated via model building using linear regression, or a mixed models 
as described below.   
The magnitude of the overnight change of LHR was individually evaluated over 
undisturbed sleep and over fragmented sleep separately.  The association of variables of sleep 
and demographic information were individually evaluated by a linear regression model via 
PROC REG procedure to assess if any predictor of interest modulates LHR on any individual 
night.   
Comparisons were then made of the differences between the magnitudes of overnight 
change of LHR using a repeated measures linear regression (PROC MIXED).  Evening before 
undisturbed sleep and morning after fragmented sleep was evaluated using the same procedures 
described for the comparison of the magnitude of overnight change of LHR. 
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6. Results 
 
Overall synopsis: Twenty-nine subjects (18 female) completed the four night / three day 
protocol with all four awake EKG recordings. The demographic characteristics are summarized 
in Table 4.  An evaluation of the effect of transient sleep on “awake” LHR recoding was found to 
show significant differences.  As a result, the two subjects that had evidence of sleep in all LHR 
epochs during a given recording period were removed from all subsequent analyses.  Paired t-
tests were used to assess if there were significant differences between the recording periods.  
Those statistically significant comparisons were further explored utilizing multivariate regression 
models with particular interest in evaluating the effect of sleep fragmentation on LHR while 
controlling for overweight. 
 
 
6.1 Outcome Variable Selection  
 
SVB is known to differ between wakefulness and sleep in normal individuals and after a 
night sleep fragmentation there was concern about inadvertent, brief sleep episodes that were not 
detected by the technician collecting the EKG data. Thus to be more assured that differences 
between SVB before and after sleep fragmentation were not confounded by undetected sleep the 
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 following exploration was conducted.  An assessment was made to determine if sleep occurring 
during the HRV recordings alters the outcome measure of LHR.  As the assessment was made, 
there were two subjects that showed evidence of sleep during at least some portion of all five two 
minute HRV analysis segments (in other words, there were no sleep-free HRV analysis segments 
during a given time point).  Those two subjects (Table 5) were removed from further analysis.  
To determine if sleep affects LHR, LHRAWAKE was compared to LHRSLEEP using repeated 
measures ANOVA.  Only those subjects that had evidence of sleep and awake during a given 
time point (i.e. EBN-2) were assessed. 
Twenty-three of 27 subjects had epochs with EEG evidence of sleep during their “awake” 
EKG recording for HRV analysis.  For those 23 subjects, there were a total of 45 out of a 
possible 92 time points affected by sleep and had evidence of awake.  For all time points the 
mean LHRAWAKE 2.30 (sd: 2.12) was compared to a mean LHRSLEEP 1.91 (sd: 1.63).  Normality 
was assessed and found that the LHRAWAKE and LHRSLEEP were skewed and not normally 
distributed based on K/S statistics and QQ plots and were thus log transformed. Reassessment 
indicated that the transformed values were normally distributed.  Log transformed, LHRAWAKE 
and LHRSLEEP were used in the subsequent analyses.  Repeated measures ANOVA had a 
significant overall F statistic (p = 0.0017) suggesting that Log LHRAWAKE was significantly 
different from Log LHRSLEEP.  Thus is was decided to use log LHRAWAKE for the remaining 
analyses.  As a consequence of using the LHRAWAKE, the two subjects that had a missing time 
point would not be included in the subsequent analyses.  Demographics for the remaining 27 
subjects are summarized in Table 6, Figure 6, and Figure 7. 
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6.2 Sleep Parameters 
 
Parameters of sleep architecture, continuity and breathing during sleep for the 27 subjects 
were summarized in Table 7.  In addition, Table 7 also reports the p value for the paired t-test 
comparing  undisturbed sleep and fragmented sleep.  The sleep variables (AHI, SFI, SWS, 
average SPO2, % TST below SPO2 90%, and TST) were all significantly affected by 
experimentally-induced sleep fragmentation to warrant further evaluation in model building.  
Figure 8 through Figure 11 displays the graphic representation of the sleep variables described in 
Table 7.  It was noted that there were subjects that did not follow the same pattern as the rest of 
the study population or had values that appeared to possibly influential.  Efforts were made to 
identify those subject(s) to see if there was a particular subject or subject characteristic that could 
explain the pattern.   
 
Appendix  lists the subjects that were identified with the value of interest underlined.  No 
subject nor any specific pattern were identified among those subjects listed. 
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6.3 The  Effect  of Transient  Sleep  Intervals  on  Low  to High  Frequency 
Ratio  
 
LHRAWAKE for the subpopulation (n=27) being assessed is summarized in Table 9.  To 
assess if Log LHRAWAKE was different at different time points a paired t-test was used (Table 
10).  There was a significant overnight increase of Log LHRAWAKE from the evening to morning 
LHRAWAKE recording on the undisturbed night of sleep (EBN-2 vs. MAN-2) (p = 0.0398) 
suggesting an increase in SVB. In contrast, there was no statistically significant overnight change 
of Log LHRAWAKE during the second night of experimentally-induced sleep fragmentation (EBN-
4 vs. MAN-4).  There was a statistically significant increase comparing the EBN-2 and EBN-4 
(P = 0.0269) Log LHRAWAKE recordings.  The comparison of the morning values revealed no 
significant difference.  The EBN-2 value compared to the MAN-4 sleep was not significant 
(P=0.0933).   
The magnitude of overnight change on the undisturbed night vs. the second fragmented 
night was also compared.  The overnight change as determined by taking the morning Log 
LHRAWAKE subtracted from evening Log LHRAWAKE values are listed in Table 11.  The overnight 
change on undisturbed night sleep verses overnight change on fragmented night sleep was 
borderline significant (P = 0.063) compared to the overnight change on fragmented sleep.   
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6.3.1 Linear Regression Comparing Morning Log Low to High Frequency Ratio 
While Awake to Evening Log Low to High Frequency Ratio While Awake during each 
Sleep Condition (Undisturbed or 2nd Fragmented Sleep) Separately 
 
Linear regression using PROC REG procedure was used to assess if overnight change 
was associated with any available covariate.  Table 12 shows that the overnight change on the 
second fragmented night sleep was not affected by any of the covariates assessed.  To further 
evaluate those significant covariates for the overnight change on an undisturbed night a stepwise 
model building process was utilized.  Model 1 shows the final model where the covariates 
selected had a p value < 0.2 in the univariate analysis as listed in Table 12.  BMI group was 
forced to remain in the model and the other covariates were permitted to leave.  The final model 
suggests that as SFI can affect Log LHR values whereas there was no significant change due to 
BMI group. 
 
 
6.3.2  Overnight  Change  of  Log  Low  to  High  Frequency  Ratio  While  Awake 
across an Undisturbed Night of Sleep verses Overnight Change of Log Low  to High 
Frequency Ratio While Awake across a 2nd night of Fragmented Night 
 
The difference of the magnitude of the overnight change of LHRAWAKE change between 
undisturbed and second night of fragmented sleep [(MAN-2 - EBN-2) vs. (MAN-4 - EBN-4)] 
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 was assessed using a repeated measures multiple linear regression.  A PROC MIXED procedure 
was used to assess the relationship.  Table 13 lists the univariate results for  the individual 
predictors on the outcome variable of Log LHRAWAKE overnight change.  Significant covariates 
were further evaluated in a stepwise model building process.  The variables assessed were 
grouped BMI, fragmented sleep indicator, averaged SpO2 during sleep and %time < SPO2 90% 
during sleep.  None of the covariates assessed remained in the final model.  Tested interactions 
provided an nonsignificant improvement in the model’s fit.   
An additional analysis (Model 2) was performed to assess whether induced sleep 
fragmentation was related to the magnitude of overnight change while taking into account the 
other covariates.  The results suggest that there was no effect of induced sleep fragmentation or 
grouped BMI on the difference of overnight change of log LHRAWAKE between N2 and N4 after 
accounting for average SpO2 and % TST<SPO2<90%.  
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There was a significant difference in BMI between the groups (P < 0.001).   
Group 1: BMI < 25 kg / m2.  Group 2: BMI > 25 kg / m2. 
 
Figure 6: Body Mass Index by Study Group (N=27) 
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There was not a significant difference in age between groups. (P > 0.2)   
Group 1: BMI < 25 kg / m2.  Group 2: BMI > 25 kg / m2. 
 
Figure 7: Age by Study Group (N=27) 
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There was a statistically significant difference in AHI between nights (P > 0.0094), where 
AHI is higher on the second night of experimentally induced sleep fragmentation.  
Figure 8: Apnea Hypopnea Index (N=27) 
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There was a statistically significant difference in SFI between nights (P < 0.0001), where 
SFI is higher on the second night of experimentally induced sleep fragmentation.   
Figure 9: Sleep Fragmentation Index (N=27) 
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There was a statistically significant difference in slow wave sleep time between Undisturbed and Second 
Night of Fragmented Sleep (P < 0.0001) where the second Fragmented night had less time in slow wave sleep.   
Figure 10: Slow Wave Sleep (N=27) 
 
 
 
 
37 
  
 
 
25
0
30
0
35
0
40
0
45
0
50
0
Ti
m
e 
m
in
 
Night
Total Sleep Time
Fragmented  NormalUndisturbed Night 2nd Fragmented Night 
 
There was a statistically significant difference in total sleep time between Undisturbed and the Second 
Night of Fragmented Sleep (P = 0.0009) where the Second Night of Fragmented night had less total sleep time.   
Figure 11: Total Sleep Time (N=27) 
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 Undisturbed Night 2nd Fragmented Night 
NS = P > 0.2; * = 0.1 > P > 0.05; ** = 0.05 > P > 0.01 
 
Figure 12: Log Low to High Frequency Ratio at Each Time Point with Significance Based 
On Table 9 and Table 10 
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Undisturbed Night 2nd Fragmented Night 
* = P = 0.0603 
 
Figure 13: Overnight Change of Log Low to High Frequency Ratio based on Table 11  
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Table 4: Study Demographics, Entire Population 
  Group 
N = 29 Population 1  2  
Female 
Male 
19 (65.5 %) 
10 (34.5 %) 
8 (57.1%) 
6 (42.9 %) 
11 (73.3 %) 
4 (26.7 %) 
BMI mean (std dev) 
(min : max) 
26.4 (6.1) 
(19.0 : 46.6) 
22.0 (2.0) 
(19.0:24.6) 
30.4 (5.8) 
(25.2:46.6) 
Age, years  
            mean (std dev) 
            (min : max) 
 
27.7 (11.4) 
(19 : 56) 
 
27.2(11.4) 
(19 : 56) 
 
28.2 (11.9) 
(19 : 56) 
NS = P > 0.2 
 
 
Table 5: Two Subjects Removed due to Missing Time Points due to Sleep-Contaminated 
Heart Rate Variability Analysis Segments  
Subject 
ID 
65 51 
Group 1 2 
Gender Male Female 
Age, yrs 19 21 
BMI 24.5 27.8 
Night Undisturbed Fragmented Undisturbed Fragmented 
SFI 9.46 26.29 13.22 25.43 
AHI 1.47 14.22 1.28 1.77 
EKG time 
point 
Evening Morning Evening Morning Evening Morning Evening Morning 
LHRALL 1.14 2.56 2.19 2.66 3.28 0.817 3.87 1.1 
LHRAWAKE 1.14 2.31 - 1.54 3.21 0.65 4.70 - 
LHRSLEEP - 3.66 2.19 2.94 - - 2.18 1.1 
BMI = Body Mass Index, SFI = sleep fragmentation index, AHI = apnea hypopnea index 
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Table 6: Subject Demographics without Epochs Scored as Sleep during Heart Rate 
Variability Data Collection (N=27)  
 
Study Population 
N = 27  Group 
P value 
  1 (BMI < 25) 2 (BMI > 25) 
Female 
Male 
18 (66.7 %) 
9 (33.3 %) 
8 (61.5 %) 
5 (38.5 %) 
10 (71.4 %) 
4 (28.6 %) NS 
BMI  
mean (sd) 
(min : max) 
 
28.3 (11.6) 
(19.0:46.6) 
 
21.9 (1.9) 
(19.0:24.6) 
 
30.6 (6.0) 
(25.2:46.6) 
0.000 
Age, years 
mean (sd) 
(min : max) 
 
26.4 (6.3) 
(19:56) 
 
27.8 (11.6) 
(19:56) 
 
28.7 (12.1) 
(19:56) 
NS 
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Table 7: Sleep Variables Compared on Undisturbed and 2nd Fragmented Night Using a 
Paired T-Test (N=27) 
N= 27 Undisturbed Night 2nd Fragmented Night P Value 
Apnea Hypopnea Index 
mean (std dev) 
(min : max) 
 
1.2 (1.1) 
(0 : 4.1)  
 
2.5 (2.9)  
(0.2 : 12.6) 
 
0.0094 
Sleep Fragmentation Index  
mean (std dev) 
(min : max) 
 
8.2 (3.3) 
(2.1 : 14.8) 
 
26.0 (3.7)  
(17.7 : 33.4) 
 
< 0.0001 
Slow Wave Sleep, min. 
mean (std dev) 
(min : max) 
 
56.6 (38.5) 
(0 : 161.0) 
 
28.7 (31.7)  
(0 : 134.7) 
 
< 0.0001 
Average SpO2 during sleep 
      mean (std dev) 
                     (min : max) 
 
96.9 (0.8) 
(95 : 98) 
 
97.2 (0.9) 
(94 : 99) 
 
0.0431 
% TST SPO2 < 90%  
                      mean (std dev) 
                     (min : max) 
 
0 (0) 
(0 : 0) 
 
0.02 (0.06) 
(0 : 0.2) 
 
0.0961 
Total Sleep Time, min.  
                         mean (std dev) 
(min : max) 
 
431.4 (63.5) 
(254.3 : 511.3) 
 
401.5 (52.3) 
(239.0 : 484.0) 
 
0.0009 
NS = Not Significant p > 0.2 
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Table 8: Percent Total Sleep Time below Pulse Oximetry 90% 
% TST below SpO2 90% Undisturbed Night 2nd Fragmented Night
0 27 24 
0.1 0 1 
0.2 0 2 
Total 27 27 
 
 
 
 
Table 9: Low to High Frequency Ratio While Awake Summarized at Each Time Point (N = 
27) 
LHRAWAKE Mean Std Dev Minimum Maximum 
Evening Before Undisturbed Sleep 1.51 0.93 0.41 3.83 
Morning After Undisturbed Sleep 2.16 1.77 0.50 8.04 
Evening Before Fragmented Sleep 2.37 1.69 0.31 6.79 
Morning After Fragmented Sleep 2.16 1.93 0.36 8.47 
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Table 10: Compared Log Low to High Frequency Ratio while Awake at Various Time 
Points Utilizing a Paired T-Test 
N = 27 
Evening Before 
Normal Sleep 
Morning after 
Normal Sleep 
Evening Before 2nd Night of 
Fragmented Sleep 
Morning After Undisturbed 
Sleep 
P = 0.0398 - P = 0.0269 
Evening Before 2nd Night of 
Fragmented Sleep 
P = 0.0269 NS - 
Morning After 2nd Night of 
Fragmented Sleep 
P = 0.0933 NS NS 
NS = non-significant p >0.2  
 
 
 
 
Table 11: Log Transformed Difference of Overnight Change of Log Low to High 
Frequency Ratio While Awake (N=27) 
 
Total Population 
          
Variable                Night          Mean      Std Dev      Minimum     Maximum    
ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
Log Overnight Change    Undisturbed    0.276      0.663      -0.850       1.476      
Log Overnight Change    Fragmented     0.118      0.886      -2.380       1.505 
       ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
Log Overnight Change = Log morning -  Log night 
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Table 12: Each Row Represents a Single Univariate Regression: Linear Regression of Log 
of Overnight Change While Awake Individually Assessed on Undisturbed Sleep and 
Fragmented Sleep 
Overnight Change (Log Morning –Log  Night) 
N = 27 Undisturbed Sleep 2nd Night ofFragmented 
Sleep 
Variable β R2 P β R2 P 
Intercept Only 0.276 0.0000 0.0398 -0.118 0.0000 NS 
Age -0.0108 0.0359 NS -0.0134 0.0310 NS 
AHI 0.064 0.0119 NS 0.060 0.0140 NS 
Female -0.158 0.0131 NS -0.375 0.0414 NS 
Overweight 0.287 0.0484 NS 0.016 0.0001 NS 
SFI -0.074 0.1351 0.0593 0.027 0.0124 NS 
Avg SPO2 -0.249 0.0859 0.1380 -0.138 0.0174 NS 
Time <SPO2 90% - - - -2.862 0.0324 NS 
SWS 0.0001 0.0001 NS -0.0022 0.0064 NS 
TST -0.0004 0.0012 NS -0.0016 0.0085 NS 
NS = non-significant p >0.2.  SFI was treated as a continuous variable.  Overweight is an 
indicator variable with BMI < 25 kg/m2 as the baseline. 
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Table 13: Each Row Represents a Single Univariate Regression: Repeated Measures 
Linear Regression of the Comparison of Overnight Change of Log Low to High Frequency 
Ratio While Awake 
N = 27 Overnight Change (Log Morning - Log Night) 
Variable β -2 Log Likelihood AIC P 
Intercept Only 0.1416 125.9 133.9 0.1918 
Age -0.0117 124.2 134.2 NS 
AHI 0.0066 125.8 135.8 NS 
Female -0.235 124.7 134.7 NS 
Fragmented Sleep -0.394 122.1 132.1 0.0558 
Overweight 0.198 125.0 135.0 NS 
Avg SPO2 -0.245 122.2 132.2 0.0617 
% TST < SPO2 90% -4.380 123.8 133.8 0.1529 
SWS 0.0013 125.6 135.6 NS 
TST 0.0002 125.8 135.8 NS 
NS = Not significant p > 0.2 Fragmented Sleep is an indicator variable with undisturbed 
sleep as the baseline.  Overweight is an indicator variable with BMI < 25 kg/m2 as the baseline. 
 
 
 
 
Model 1: Linear Regression of Log Low to High Frequency Ratio While Awake on 
Undisturbed Night Sleep 
Log LHRAWAKE Change on Undisturbed Night Sleep 
 
Parameter                                   Standard   
Label               DF       Estimate       Error         t Value    Pr > |t| 
 
Intercept           1        0.73922        0.35445       2.09       0.0478 
SFI                 1       -0.07440        0.03762      -1.98       0.0596 
Overweight          1        0.28158        0.24060       1.17       NS 
 
Log Overnight change = Log MAN-2 vs. Log EBN-2 
Overweight is an indicator variable with BMI < 25 kg/m2 as the baseline 
NS = Not significant p > 0.2 
 
47 
  
 
 
 
Model 2: Overnight Change of Log Low to High Frequency Ratio While Awake Compared 
on Undisturbed Night verses 2nd Fragmented Night 
                                             Standard 
  Effect                      Estimate       Error        DF      t Value    Pr > |t| 
 
  Intercept                   26.3662        12.8053      25       2.06       0.0501 
  Overweight                   0.1828         0.2021      25       0.90       NS 
  Fragmented Sleep             0.2083         0.2042      25      -1.02       NS 
  Avg SpO2 during sleep       -0.2702         0.1320      25       -2.05      0.0513 
  % TST < SPO2 90%            -5.7128         3.0880      25      -1.85       0.0762 
 
Fragmented Sleep is an indicator variable with Undisturbed sleep as the baseline 
Overweight is an indicator variable with BMI < 25 kg/m2 as the baseline  
Log Overnight change = Log Morning - Log Night 
NS = Not significant p > 0.2 
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7. Discussion 
 
OSAH patients have increased sympathetic activity during sleep that sustains through 
daytime wakefulness.[43-45]  Which, if any of the specific components of OSAH, intermittent 
hypoxemia or sleep fragmentation contributes to elevated sympathetic activity is uncertain.  This 
analysis, which is part of a larger parent study, was designed to evaluate the effect of sleep 
fragmentation on cardiac SVB while adjusting for obesity in a non-OSAH population.  The main 
conclusions of this analysis were as follows: 
 
1. Transient sleep intervals during a 10 minute recording period during which the 
subject is behaviorally assessed to be awake can significantly alter LHR. This 
highlights the need to objectively confirm wake-sleep state during assessment of 
awake SVB. 
2. SVB is different in the morning following undisturbed sleep compared with the 
previous evening. 
3. One night of sleep fragmentation is associated with altered SVB that is sustained 
at least until the following evening. 
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7.1. Sleep Parameters 
 
Compared with a night without induced sleep interruption, the second night during which 
there was experimentally-induced sleep fragmentation was associated with statistically 
significant change in AHI, SWS, average SPO2, and TST decreased (Table 7).  Percent TST 
below SpO2 90% showed a borderline significant increase due to sleep fragmentation.  Increased 
SFI suggests that goal of inducing sleep fragmentation was obtained.  The decreased SWS and 
decreased TST was a consequence attributed to the induced sleep fragmentation.  Our goal was 
to arouse, but not awaken subjects from clearly established sleep (i.e. stage 2 or deeper).  If 
subjects uniformly did not awaken and remain awake for periods of time it would have been 
expected that TST would not have decreased, but time spent in deeper stages of sleep SWS may 
have nonetheless been decreased.  There was a mean reduction of TST by 29.91 (standard error 
7.99) minutes from undisturbed to the second night of fragmented sleep. Although it is 
statistically significant, the biological and clinical significance of this difference is uncertain. It 
should be noted that in contrast to our study, Tasali et al. employed a similar sleep fragmentation 
protocol that did not observe a reduction in TST but like us did reduce SWS time. [46]  This 
difference between the two studies may be explained by differences in the study populations with 
that of Tasali et al. reflected by a smaller, younger and “lean” study sample (n=9 subjects, 20-31 
years of age, BMI: 19-24); so, it appears that ours was much more diverse and representative of 
the community.   
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 There were potentially important difference between our protocol for recording HRV and 
that of Tasali et al. In contrast to our protocol which recorded HRV data just prior to bed and just 
after awakening, Tasali and coworkers collected data at midday, between 11:00 and 13:00 and 
the authors did not report activity levels prior to this collection.  Our subjects were requested to 
have an empty bladder and lay motionless for 10 minutes prior to EKG recording, as these 
factors could affect SVB.  The differences in posture during recording (Tasali’s et al. subjects 
were sitting up, our subjects were supine) could also cause differences in SVB. 
 
 
7.2 The  Effect  of Transient  Sleep  Intervals  on  Low  to High  Frequency 
Ratio  
 
The effect of transient sleep on awake LHR was evaluated using a spectral analysis of 
heart beat-to-beat intervals.  LHR based on data containing epochs “contaminated” by EEG 
evidence of sleep was statistically different from LHR based exclusively on epochs identified by 
EEG as awake.  As such only epochs without sleep were used in these analyses.  This finding 
contradicts Burgess et. al. that used pre-ejection period to measure cardiac sympathetic activity 
that did not show sympathetic activity change with transient change in the sleep/wake state.[47]  
LHR with sleep staging considered would be used for all further analyses of the cardiac 
sympathetic activity in this paper.   
LHR in the evening prior to the baseline night of undisturbed sleep (EBN-2) was 
significantly lower from than in the evening prior to the second night of experimental sleep 
fragmentation (EBN-4).  In this regard it is important to note that overnight conditions to which 
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 subjects were exposed prior to the baseline undisturbed night (reflecting a night without 
experimental sleep disruption) differed from that on the night prior to the second experimentally-
induced sleep fragmentation night (during which by definition, subjects’ sleep was disrupted).  
These findings are consistent with the posit that one night of fragmented sleep is associated with 
sustained elevation of SVB that lasts at least until the following evening.  The morning after 
sleep LHR values were not significantly different between sleep conditions.    
 
 
7.2.1 Linear Regression Comparing Morning Log Low to High Frequency Ratio 
While  Awake  to  Evening  Log  Low  to  High  Frequency  Ratio  While  Awake  during 
Undisturbed Sleep 
 
Although borderline significant, multivariate analysis of overnight change of Log 
LHRAWAKE on the undisturbed night’s sleep was suggestive of an inverse association with SFI.  
This suggests that SFI could modulate LHR overnight change on an undisturbed night sleep.  A 
similar analysis for fragmented night sleep resulted in no significant association for any of the 
covariates assessed. 
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7.2.2  Overnight  Change  of  Log  Low  to  High  Frequency  Ratio  While  Awake 
across an Undisturbed Night of Sleep verses Overnight Change of Log Low  to High 
Frequency Ratio While Awake across a 2nd night of Fragmented Night 
 
Comparison of the overnight change using a paired t-test resulted in a borderline 
significant decrease of the magnitude of the overnight change due to fragmented sleep.  Further 
multivariate analysis resulted in non significant contributions of grouped weight or fragmented 
sleep.  Measures of oxygenation (% TST below SpO2 90% during sleep and average SpO2 during 
sleep) were borderline significant and had a negative effect on the magnitude of the change.  
That is to say that as the subjects experienced increasing % TST below SpO2 90% and increasing 
average SpO2 during sleep,  the magnitude of overnight change on the second fragmented night 
decreased.  
 
 
7.3 Conclusion  
 
There is an increase in awake cardiac SA from the evening before to the morning after a 
night of undisturbed sleep.  The results of this study suggest that a night of fragmented sleep 
significantly increases awake cardiac sympathetic activity on the following evening to levels 
compared to the evening values prior to undisturbed sleep and not significantly different from the 
morning values after undisturbed sleep.  Multivariate regression models suggest that fragmented 
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 sleep while adjusting for obesity could not explain the observed differences in the magnitude of 
overnight change of the different sleep conditions.  Being overweight or obese did not 
significantly change cardiac sympathovagal tone.  This supports a similar finding by Narkiewicz 
et. al. where MSNA was not increased due to obesity in non-OSAH subjects.[48] 
A possible explanation could be a plateau effect of the amount of SFI.  After a night of 
moderately induced sleep fragmentation, the SVB cannot increase any further (a ceiling effect).  
Another possible explanation could be that SFI can only elevate the evening LHR recording 
(carryover effect) as suggested by the evening values being statically different, and the morning 
values being statically similar.  Further changes in LHR could be due to the deoxygenation-
reoxygenation cycle of the obstructive events.   The idea of the plateau effect could be supported 
by a measure of oxygenation (Average SpO2, or % time below SpO2 90%) remained in the final 
model assessing the differences in the magnitude of the overnight change.  Moderately induced 
sleep fragmentation could not explain the differences observed in this population due to induced 
sleep fragmentation.   
 
 
7.4 Study Limitations 
 
Our conclusions are qualified by the limitation of the parent study design. We do not 
have LHR readings for evening before the first night of undisturbed sleep, morning after first 
night of sleep, evening before first fragmented night, and the morning after the first fragmented 
night.  LHR recording associated with the acclimatization night would be highly susceptible to 
unknown sleep conditions (evening recording) and the first night effect (morning recording).  
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 The addition of another baseline night and the addition of another fragmented sleep night, we 
could have provided a better understanding whether the changes are due to within subject 
variation or due to experimental conditions.  In addition, we recognize that OSAH is a chronic 
disorder and that assessing SVB after only two nights of sleep fragmentation may not be truly 
representative of what happens in OSAH.   
The order of sleep experienced was not randomized (e.g. undisturbed sleepalways 
preceded fragmented sleep).  With the assumption that there would need at least one undisturbed 
night (and maybe more) between both conditions, this would have increased the total time spent 
in the study environment to 6 nights (acclimation / screening night, sleep condition 1 for two 
nights, washout night, sleep condition 2 for two nights).  Logistic limitations associated with 
subjects staying in a carefully controlled environment and participant burden required a 
compromise of a 4 night protocol. 
The elevated sympathetic activity could be in part due to an unequal parasympathetic 
withdrawal instead of an increase in sympathetic activation.  Also conceivable is that the 
morning LHR reading could be artificially increased due to a technician possibly stimulating the 
subject by awakening her/him for the morning EKG reading.  Changes in breathing rate could 
also have an impact on the LHR reading, breathing rate data was not available during the awake 
EKG recording.[45]   
This was a sub study from a larger study. The parent study was not optimized (e.g. 
statistical power) for assessing differences in LHR (Appendix B: Statistical Power Calculations). 
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Appendix A: Subjects with Unexpected Values  
 
 
Subjects with unexpected values based on graphic representations of their recordings were 
further assessed to determine if there was a pattern or a small number of subjects that would 
explain the unexpected values observed (Table 14).  
 
 
 
 
Table 14: Subjects with Unexpected Values Underlined 
Subject ID 40 78 
Age 23 24 
Gender Male Female 
BMI 26.70 19.50 
Study Group 2 1 
Night Undisturbed Fragmented Undisturbed Fragmented 
TST 423.33 386.67 473 484  
SFI 4.68 28.86 5.2 17.73 
SWS 105.33 13 161 134.67 
AHI 4.11 12.57 0.76 9.55    
Avg SPO2 97 97 97 97 
% Time Below SPO2 
90% 0 0 0 0 
Time Point EBN-2 MAN-2 EBN-4 MAN-4 EBN-2 MAN-2 EBN-4 MAN-4 
LHRAwake 1.663 2.724 2.985 7.453 2.863 5.166 1.787 2.503 
LHRSLEEP - - - 4.370 - - 1.010 - 
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Table 14: Subjects with Unexpected Values , continued 
Subject ID 8 10 
Age 21 23 
Gender Male Male 
BMI 26.10 20.10 
Study Group 2 1 
Night Undisturbed Fragmented Undisturbed Fragmented 
TST, min. 426.67 419 454.33 434.33 
SFI 14.2 33.37 6.87 28.04 
SWS, min. 82.66 88 14.33 30.33    
AHI 1.69 0.86 0.79 0.83 
Avg SPO2, % 97 97 97 98 
% TST Below SpO2 
90% 0 0.2  0 0 
Time Point EBN-2 MAN-2 EBN-4 MAN-4 EBN-2 MAN-2 EBN-4 MAN-4 
LHRAwake 3.826 3.258 3.900 1.265 0.533 1.190 0.512 2.306 
LHRSLEEP 1.250 - 4.240 1.930 0.380 - - 0.880 
 
 
 
 
Table 14: Subjects with Unexpected Values , continued 
Subject ID 70 20 
Age 56 22 
Gender Female Female 
BMI 20.60 35.20 
Study Group 2 2 
Night Undisturbed Fragmented Undisturbed Fragmented 
TST, min. 296 345.67  430 413.67 
SFI 11.15 30.55 6.56 26.4 
SWS, min. 0 7.67 66.66 67.33    
AHI 0.61 0.17 0.28 2.76 
Avg SPO2, % 98 97 96 97 
% TST Below SpO2 
90% 0 0 0 0 
Time Point EBN-2 MAN-2 EBN-4 MAN-4 EBN-2 MAN-2 EBN-4 MAN-4 
LHRAwake 1.984 0.848 6.790 1.815 0.735 1.520 1.703 0.660 
LHRSLEEP - 0.830 5.560 - - - - - 
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Table 14: Subjects with Unexpected Values , continued 
Subject ID 34 140 
Age 19 47 
Gender Female Male 
BMI 33.70 25.20 
Study Group 2 2 
Night Undisturbed Fragmented Undisturbed Fragmented 
TST, min. 499.67 471.33 254.33 239 
SFI 14.77 17.69  7.79 25.1 
SWS, min. 58.33 17.67 9.67 0.33 
AHI 2.88 4.46 1.89 4.77 
Avg SPO2, % 97 97 95 94 
% TST Below 
SpO2 90% 
0 0.1 0 0.2    
Time Point EBN-2 EBN-2 EBN 4 MAN 4 EBN-2 MAN-2 EBN-4 MAN-4 
LHRAwake 1.320 1.320 3.555 1.268  1.323 5.786 3.783 4.580 
LHRSLEEP 1.500 1.500 1.767 - - - - - 
 
 
Table 14: Subjects with Unexpected Values , continued 
Subject ID 86 87 
Age 31 26 
Gender Female Female 
BMI 31.30 27.80 
Study Group 2 2 
Night Fragmented Fragmented Undisturbed Fragmented 
TST, min. 291.33 369.333 425.33 437.33    
SFI 11.74 29.57 3.1 25.11 
SWS, min. 7.33 4.33 62.67 40.33 
AHI 0.41 0.81 0 0.41 
Avg SPO2, % 97 97 97 98 
% TST Below 
SpO2 90% 
0 0 0 0 
Time Point EBN-4 MAN-4 EBN-4 MAN-4 EBN-2 MAN-2 EBN-4 MAN-4 
LHRAwake 1.678 1.320 0.310 1.040 0.535 1.158 1.125 1.042 
LHRSLEEP - - 0.550 - - - - - 
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Appendix B: Statistical Power Calculations 
 
Statistical power calculations were performed to determine how under powered the sub-
study was (Table 15) based on the observed difference of the means and observed standard 
deviation.  Additional calculations were done to determine the sample size needed to detect a 
difference based on the observed difference and standard deviation (Table 16).  Also calculated 
was the minimum statistically significant difference of the means based on the available sample 
size and observed standard deviations (Table 17). 
 
Table 15: Power Calculation for Detecting a Difference of the Observed Means and 
Observed Standard Deviation Using a Two-Sided Paired T-Test for a Sample Size of 27 
with a Significance Level (Alpha) of 0.05 
N = 27 
Alpha = 0.05 Power Effect size
Difference of 
the means 
Standard 
deviation 
Change on undisturbed night  
(MAN-2 – EBN 2) 55% 0.417 0.28 0.66 
Change on fragmented night  
(MAN-4 – EBN-4) 10% 0.133 0.12 0.89 
Difference of the changes 
[(MAN-4 – EBN-4)  
vs. 
(MAN-2 – EBN-2)] 
50% 0.378 0.39 1.04 
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Table 16: Sample Size Calculation for Detecting a Difference of the Observed Means and 
Observed Standard Deviation using a Two-Sided Paired T-Test for Power of 80% with a 
Significance Level (Alpha) of 0.05 
Power = 80% 
Alpha = 0.05 
Sample 
size 
Effect 
size 
Difference of 
the means 
Standard 
deviation 
Change on undisturbed 
night (MAN-2 – EBN 2) 48 0.417 0.28 0.66 
Change on fragmented night 
(MAN-4 – EBN-4) 444 0.133 0.12 0.89 
Difference of the changes 
[(MAN-4 – EBN-4)  
vs. 
(MAN-2 – EBN-2)] 
55 0.378 0.39 1.04 
 
 
 
Table 17: Minimum Detectable Difference of the Means Based on Observed Standard 
Deviations using a Two-Sided Paired T-Test for Power of 80% with a Significance Level 
(Alpha) of 0.05 and a Sample Size of 27 
Power = 80% 
Alpha = 0.05 
N = 27 
Minimum Detectable 
Difference of the means 
Standard 
deviation Effect size 
Change on undisturbed night 
(MAN-2 – EBN 2) 0.4 0.66 0.539 
Change on fragmented night 
(MAN-4 – EBN-4) 0.5 0.89 0.539 
Difference of the changes 
[(MAN-4 – EBN-4) 
vs. 
(MAN-2 – EBN-2)] 
0.6 1.04 0.539 
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